Published in Thorax on March 01, 1994
Effect of dexamethasone and endogenous corticosterone on airway hyperresponsiveness and eosinophilia in the mouse. Br J Pharmacol (1996) 0.89
A local circadian clock calls time on lung inflammation. Nat Med (2014) 0.76
Sleep-related breathing disorders. 7. Sleep and breathing problems in general medicine. Thorax (1995) 0.75
Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. N Engl J Med (1980) 3.04
Nocturnal asthma: a study in general practice. J R Coll Gen Pract (1989) 2.55
Interleukin 4 is localized to and released by human mast cells. J Exp Med (1992) 2.00
IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. J Immunol (1990) 1.86
Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis (1992) 1.75
Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is alpha 4 beta 1 (very late antigen-4) dependent. J Immunol (1991) 1.67
Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J Clin Invest (1991) 1.65
Parasympathetic nervous system in nocturnal asthma. Br Med J (Clin Res Ed) (1988) 1.57
Hydrogen peroxide and superoxide release by alveolar macrophages from normal and BCG-vaccinated guinea-pigs after intravenous challenge with Mycobacterium tuberculosis. Br J Exp Pathol (1981) 1.39
Airways inflammation in nocturnal asthma. Am Rev Respir Dis (1991) 1.26
Human eosinophils express functional interleukin 2 receptors. J Clin Invest (1991) 1.26
Snoring, asthma and sleep disturbance in Britain: a community-based survey. Eur Respir J (1993) 1.12
Bronchoscopy with bronchoalveolar lavage causes neutrophil recruitment to the lower respiratory tract. Am Rev Respir Dis (1991) 1.11
Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis (1992) 1.03
Extracellular release of hydrogen peroxide by human alveolar macrophages: the relationship to cigarette smoking and lower respiratory tract infections. Clin Sci (Lond) (1983) 0.97
Plasma histamine, epinephrine, cortisol, and leukocyte beta-adrenergic receptors in nocturnal asthma. Clin Pharmacol Ther (1991) 0.96
Is nocturnal asthma caused by changes in airway cholinergic activity? Thorax (1988) 0.87
Nocturnal airflow obstruction, histamine, and the autonomic central nervous system in children with allergic asthma. Thorax (1991) 0.85
Circulating histamine and eosinophil cationic protein levels in nocturnal asthma. Clin Sci (Lond) (1992) 0.81
Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet (1993) 7.12
Transient hypoxaemia during sleep in chronic bronchitis and emphysema. Lancet (1979) 4.85
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy (2009) 4.10
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy (2009) 3.86
The sleep hypopnea syndrome. Am Rev Respir Dis (1988) 3.31
Single-dose slow-release aminophylline at night prevents nocturnal asthma. Lancet (1982) 3.21
Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med (2001) 3.19
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10
Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med (1999) 2.98
Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med (1997) 2.98
Gutter treatment for ingrowing toenails. Br Med J (1979) 2.96
Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med (1999) 2.77
In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J Immunol (1996) 2.74
Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med (2001) 2.68
Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet (1994) 2.68
Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest (1996) 2.58
Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax (1997) 2.47
Perforation of chronic peptic ulcers after cimetidine. Br Med J (1977) 2.46
Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax (1990) 2.43
Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. Eur Respir J (2003) 2.42
Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34
Isolation and characterization of soluble boron complexes in higher plants. The mechanism of phloem mobility of boron. Plant Physiol (1997) 2.29
Pseudomonas cepacia in inpatients with cystic fibrosis. Lancet (1991) 2.27
Influencing the national training agenda. The UK & Ireland orthopaedic eLogbook. J Bone Joint Surg Br (2005) 2.25
Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr Res (1993) 2.22
Accuracy sensitivity to carboxyhemoglobin, and speed of response of the Hewlett-Packard 47201A ear oximeter. Am Rev Respir Dis (1979) 2.17
Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. Arch Intern Med (1992) 2.15
Neck soft tissue and fat distribution: comparison between normal men and women by magnetic resonance imaging. Thorax (1999) 2.12
The management of acute acromioclavicular dislocation. A randomised prospective controlled trial. J Bone Joint Surg Br (1989) 2.11
Lung cancer: the importance of seeing a respiratory physician. Eur Respir J (2003) 2.08
Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions. J Biol Chem (2001) 2.07
Recombinant DNase in cystic fibrosis: a protocol for targeted introduction through n-of-1 trials. Scottish Cystic Fibrosis Group. Eur Respir J (1999) 2.05
Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med (1999) 2.02
Sleep apnoea: clinical importance and facilities for investigation and treatment in the UK. Addendum to the 1993 Royal College of Physicians Sleep Apnoea report. J R Coll Physicians Lond (1999) 2.01
The effect of nonvisible sleep fragmentation on daytime function. Am J Respir Crit Care Med (1997) 1.98
Intra-articular distension and steroids in the management of capsulitis of the shoulder. BMJ (1991) 1.93
Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax (2007) 1.93
Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax (2004) 1.93
Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene (1994) 1.91
Translational repression in eukaryotes: partial purification and characterization of a repressor of ferritin mRNA translation. Proc Natl Acad Sci U S A (1988) 1.91
Permeability and channel-mediated transport of boric acid across membrane vesicles isolated from squash roots. Plant Physiol (2000) 1.88
The increasing incidence of fractures of the proximal femur: an orthopaedic epidemic. Lancet (1983) 1.86
Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome. Thorax (1994) 1.85
Uvulopalatopharyngoplasty may compromise nasal CPAP therapy in sleep apnea syndrome. Am J Respir Crit Care Med (1996) 1.84
Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis (1991) 1.84
Incidence of distal forearm fracture in British men and women. Osteoporos Int (2001) 1.79
Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax (1998) 1.77
Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. BMJ (1990) 1.73
Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis. Eur Respir J (1998) 1.72
Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep (2000) 1.66
Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging. Eur Respir J (2005) 1.66
Irregular breathing and hypoxaemia during sleep in chronic stable asthma. Lancet (1982) 1.65
Outcomes in post-ICU mechanical ventilation: a therapist-implemented weaning protocol. Chest (2001) 1.62
Hypoxic ventilatory response decreases during sleep in normal men. Am Rev Respir Dis (1982) 1.62
The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis (1982) 1.62
Cutaneous vasoconstrictor response to glucocorticoids in asthma. Lancet (1991) 1.61
Neck and total body fat deposition in nonobese and obese patients with sleep apnea compared with that in control subjects. Am J Respir Crit Care Med (1998) 1.61
Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. Br J Dermatol (2014) 1.60
Bronchodilatation and the site of airway resistance in severe chronic bronchitis. Thorax (1979) 1.60
Human skin mast cells: their dispersion, purification, and secretory characterization. J Immunol (1987) 1.58
Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome. Am Rev Respir Dis (1983) 1.58
Clinical features of the sleep apnoea/hypopnoea syndrome. Q J Med (1989) 1.56
Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry (2006) 1.55
Bile duct cells in primary biliary cirrhosis are 'primed' for apoptosis. Eur J Gastroenterol Hepatol (1998) 1.55
Visna virus encodes a post-transcriptional regulator of viral structural gene expression. Proc Natl Acad Sci U S A (1990) 1.55
The effect of sleep fragmentation on daytime function. Am J Respir Crit Care Med (1996) 1.55
Proceedings: The inhibitory effect of insulin on pinnal anaphylaxis in the mouse. Br J Pharmacol (1974) 1.54
Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging. Thorax (1992) 1.54
Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids. Respir Med (1991) 1.53
Permeability of boric acid across lipid bilayers and factors affecting it. J Membr Biol (2000) 1.52
The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors. Oncogene (2007) 1.52
Tamoxifen prevention of breast cancer: an instance of the fingerpost. J Natl Cancer Inst (1999) 1.52
Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema; effects on plasma brain natriuretic peptide concentrations. Eur Heart J (2002) 1.52
Under reporting of sleepiness and driving impairment in patients with sleep apnoea/hypopnoea syndrome. J Sleep Res (1997) 1.51
Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax (2002) 1.51
A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol (1995) 1.50
Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. J Natl Cancer Inst (2000) 1.50
Respiration during sleep in normal man. Thorax (1982) 1.49
Hypercapnic ventilatory response in sleeping adults. Am Rev Respir Dis (1982) 1.48
Retrograde fixation of fractures of the neck and shaft of the humerus with the 'Halder humeral nail'. Injury (2001) 1.47
Evaluation of Biox IIA ear oximeter. Thorax (1985) 1.46
Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest (1998) 1.46
Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides. J Immunol (1982) 1.45
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone. Mol Endocrinol (2011) 1.45
Plant nutrition for sustainable development and global health. Ann Bot (2010) 1.44
Use of saturation mutagenesis to localize probable functional domains in the NahR protein, a LysR-type transcription activator. J Biol Chem (1990) 1.44
Alcohol and cor pulmonale in chronic bronchitis and emphysema. BMJ (1993) 1.44
Histamine release upon adenosine 5'-monophosphate (AMP) nasal provocation in allergic subjects. Thorax (1999) 1.43
cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene (1999) 1.42
Does arousal frequency predict daytime function? Eur Respir J (1998) 1.41
Immunoglobulin E decapeptide-induced 5-hydroxytryptamine release from rat peritoneal mast cells. Comparison with corticotropin-(1-24)-peptide, polyarginine, polylysine and antigen. Biochem J (1981) 1.41
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy (2002) 1.41
The effect of age, sex, obesity and posture on upper airway size. Eur Respir J (1997) 1.41
Pre-clinical applications of transgenic mouse mammary cancer models. Transgenic Res (2002) 1.40
Breathing patterns during sleep in patients with nocturnal asthma. Thorax (1987) 1.39
Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. Biochem Pharmacol (1984) 1.38